Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Endometrial Neoplasms 10 Uterine Cervical Neoplasms 5 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Pancreatic Neoplasms 4 Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Lung Neoplasms 2 Locally Advanced Rectal Cancer (LARC) 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Neuroendocrine 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Recurrence 1 Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) 1 Penile Neoplasms 1 Pathologic Complete Response 1 Ovarian Carcinosarcoma 1 Oropharyngeal Neoplasms 1 Neoplasms, Second Primary 1 Mouth Neoplasms 1

Interventions

niraparib 1 dostarlimab 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ovarian Carcinosarcoma × dostarlimab × Clear all

NCT03651206 2026-06-01

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡